From the Clinic to the Laboratory, and Back Again: Investigations on Cannabinoids and Endocannabinoid System Modulators for Treating Schizophrenia.

Front Psychiatry · 2021 · PMC8287066 · PMID 34290632

Europe PMC DOI

hedged sentence

0.0680

closest p · 1.4× alpha

0.0680

boldest claim

The sentences

nearly significantp = 0.068so close (0.05 < p ≤ 0.1)

Executive function, assessed by the Brief Assessment of Cognition in Schizophrenia (BACS), showed a nearly significant improvement in the CBD group ( p = 0.068).

also in 3,279 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.